Expression of vascular endothelial growth factors A and C in human pancreatic cancer
Authors:
- Rui-Feng TangRTRui-Feng Tang
- Shu-Xia WangSWShu-Xia Wang
- Li PengLPLi Peng
- Shun-Xiang WangSWShun-Xiang Wang
- Meng ZhangMZMeng Zhang
- Zhi-Feng LiZLZhi-Feng Li
- Zhi-Ming ZhangZZZhi-Ming Zhang
- Yan XiaoYXYan Xiao
- Feng-Rui ZhangFZFeng-Rui Zhang
Open Access
- 1 January 2006
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 12 (2) , 280-286
Abstract
AIM: To study the expression of vascular endothelial growth factor A (VEGF - A) and VEGF - C and to determine whether the presence of VEGF - A and VEGF - C was associated with the clinicopathologic characteristics of pancreatic cancer. METHODS: VEGF - A and VEGF - C mRNA transcripts were examined by Northern blot in 6 human pancreatic cancer cell lines and 8 normal pancreatic tissues and 8 pancreatic carcinoma specimens. The expression of VEGF - A and VEGF - C proteins was examined by Western blot in the tested cell lines and by immunohistochemical stain in 50 pancreatic carcinoma samples. RESULTS: VEGF - A and VEGF - C mRNA transcripts were present in all the 6 human pancreatic cancer cell lines. Immunoblotting revealed the presence of VEGF - A and VEGF - C proteins in all the cell lines. Northern blot analysis of total RNA revealed 3.0-fold and 3.6 - fold increase in VEGF - A and VEGF - C mRNA transcript in the cancer samples, respectively. Immunohistochemical analysis confirmed the expression of VEGF - A and VEGF - C in cancer cells within the tumor mass. Immunohistochemical analysis of 50 pancreatic cancer tissue samples revealed the presence of VEGF-A and VEGF - C immunoreactivity in 50% and 80% of the cancer tissue samples, respectively. The presence of VEGF-A in these cells was associated with larger tumor size and enhanced local spread (χ2 = 6.690, P = 0.0352 = 5.710, P = 0.017<0.05), but was not associated with decreased patient survival. There was no correlation between the expression of VEGF - A and VEGF - C in the same cancer cells. CONCLUSION: VEGF - A and VEGF-C are commonly overexpressed in human pancreatic cancer and may contribute to tumor growth and lymph node metastasis. There is no relationship between the expression of VEGF - A and VEGF - C in pancreatic cancer.Keywords
This publication has 38 references indexed in Scilit:
- Vascular Endothelial Growth Factor C Promotes Lymph Node Metastasis in a Rectal Cancer Orthotopic ModelSurgery Today, 2005
- The angiogenic switch for vascular endothelial growth factor (VEGF)‐A, VEGF‐B, VEGF‐C, and VEGF‐D in the adenoma–carcinoma sequence during colorectal cancer progressionThe Journal of Pathology, 2003
- Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancerInternational Journal of Cancer, 1999
- Expression of the Vascular Endothelial Growth Factor C Receptor VEGFR-3 in Lymphatic Endothelium of the Skin and in Vascular TumorsThe American Journal of Pathology, 1998
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumorHepatology, 1996
- Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumorHepatology, 1996
- Association of Vascular Endothelial Growth Factor Expression with Tumor Angiogenesis and with Early Relapse in Primary Breast CancerJapanese Journal of Cancer Research, 1994
- Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha.Journal of Clinical Investigation, 1992
- Distribution of Extracellular Matrix Proteins in Pancreatic Ductal Adenocarcinoma and Its Influence on Tumor Cell Proliferation in VitroPancreas, 1987